The Healthcare Practice at Frost & Sullivan, a Global Growth Partnership Company, is pleased to host an Analyst Briefing titled ‘Cardiovascular Drugs holds the potential in KSA and UAE: Know the market trends – current and future’, scheduled for Wednesday, April 20th, 2011 at 4:30 pm U.A.E Time.
The growing burden of Cardiovascular and allied diseases has ushered opportunity for pharmaceutical companies globally with their cardiovascular drug portfolio. To successfully foray and operate in any geographic market require an in-depth understanding of market dynamics, trends and future scenario of the market. This briefing aims to provide an in-depth coverage of the cardiovascular drugs market in private channel including segments such as anti-hypertensive and lipid lowering.
This briefing is going to benefit the companies who are either considering an entry into these markets or a new entrant with their cardiovascular product portfolio. Apart from pharmaceutical companies, channel partners and investors will derive benefit from such briefing.
Highlights of the briefing include analysis of external challenges such as drivers and restraints, revenue trends and forecast overall cardiovascular drugs market and its market segments.
According to Frost & Sullivan,“The KSA and UAE markets for cardiovascular drugs hold great potential for pharmaceutical companies with skewed demographic profile towards baby boomers, higher incidences of lifestyle diseases including cardiovascular ailments, diabetes, etc. and a prosperous economy. Frost & Sullivan’s latest analyst briefing will examine the value proposition offered by the KSA and UAE cardiovascular markets and evaluate their position as potential markets for pharmaceutical players.”
To participate in this briefing, or for an interview, please contact Tanu Chopra/ Nimisha Iyer at tanu.chopra[.]frost.com / niyer[.]frost.com with the following information: your full name, company name, title, telephone number, office email id, address, city, state, and country. Upon receipt of the above information, a registration link will be emailed to you. You may also register to receive a recorded version of the briefing by submitting the aforementioned details.
About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation, and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 50 years of experience in partnering with Global 1000 companies, emerging businesses, and the investment community from 40 offices across six continents.